Results 311 to 320 of about 233,257 (341)

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

Lancet Psychiatry,the, 2019
Marta Di Forti, Diego Quattrone, Tom P Freeman   +2 more
exaly  

Psychotic disorders.

The New Zealand medical journal, 1988
K, Zelas, P, Joyce
openaire   +1 more source

Psychotic Disorders

2021
openaire   +1 more source

An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders

Psychological Medicine, 2013
Jim van Os
exaly  

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

Translational Psychiatry, 2012
Dagmar Koethe
exaly  

Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies

World Psychiatry, 2013
John M Kane, Taishiro Kishimoto
exaly  

Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective

Neuropsychology Review, 2018
Julia, Nicole R Karcher, Deanna Barch
exaly  

Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study

Nature Communications, 2015
G Paul Amminger, Claudia Klier, Patrick D Mcgorry   +2 more
exaly  

Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients

Nature Communications, 2017
Emily Johansson, Julien P Dupuis, Veronique Rogemond   +2 more
exaly  

Psychotic Disorders

2014
openaire   +1 more source